
Idiopathic Hypersomnia in Australia: Why Diagnosis and Treatment Are So Hard to Access
Idiopathic hypersomnia (IH) is a chronic neurological disorder causing overwhelming daytime sleepiness and severe sleep inertia, unrelated to how much sleep someone gets. In Australia, patients face major barriers: low awareness among GPs, no distinct diagnostic code, long public-system wait times for sleep studies, and zero TGA-approved medications, meaning all treatment is off-label and PBS coverage is inconsistent. Lifestyle changes rarely control symptoms on their own. Patients can push for change by advocating with the TGA/PBAC, connecting with groups like the Sleep Health Foundation and Hypersomnia Foundation, and joining research studies.





